Biotechnology News

HOUSTON, July 07, 2026 (GLOBE NEWSWIRE) -- CoRegen, Inc., a biopharmaceutical company pursuing novel treatments for patients living with some of the most aggressive forms of cancer, today announced...

ART5 is designed to address the most common root cause of ADPKD by targeting PKD1, potentially restoring PC1 production in approximately 85% of patientsFirst-in-human SAD study in healthy volunteers...

- VIRAGE2 exploratory study designed to refine dosing regimen to potentially improved outcomes in a future pivotal Phase 3 clinical trial - - Study builds on positive clinical data from the recent...

Certara partners with NVIDIA to advance its open, integrated AI platform for drug discovery and development with the BioNeMo Agent Toolkit

Nu-Tek will present data showing how its animal-free culture media nutrients improve yield, enhance processes, and strengthen supply security at SIMB 2026.

Nu-Tek présentera des données démontrant comment ses nutriments pour milieux de culture sans composants d’origine animale améliorent le rendement, optimisent les procédés et renforcent la sécurité...

Nu-Tek wird Daten vorstellen, die zeigen, wie die tierfreien Nährstoffe für Kulturmedien die Ausbeute verbessern, Prozesse optimieren und die Versorgungssicherheit in der Bioproduktion stärken. ...

Spur Therapeutics Announces First Patient Dosed in GALILEO-3 Pivotal Clinical Trial of FLT201 for the Treatment of Gaucher Disease Type 1

Vivani Medical entered into agreement with Novo Nordisk to evaluate its miniature subdermal semaglutide (GLP-1) implant for weight management

Global Collaborations Continue to Validate Dyadic’s C1 Platform and Expand Commercial Opportunity Dyadic’s Ebola preparedness work highlights C1’s potentia